Corporate PresentationDownload September 2024 Presentation Select HighlightsMay 17, 2024STAT3 Plenary Presentation at Society for Investigative Dermatology (SID) Annual MeetingView Presentation »December 7, 2023STAT6 Program Highlighted in Sanofi R&D DayAccess Webcast »October 31, 20237th Annual Dermatology Drug Development SummitView Presentation » Latest Press ReleasesNovember 25, 2024Recludix Pharma to Participate in Two Investor Conferences in DecemberRead More »November 14, 2024Recludix Pharma to Present Data Demonstrating its Oral STAT3 Inhibitor has Differentiated Efficacy and Safety as Compared to JAK/TYK2 Inhibition in In Vivo Models of Inflammatory ArthritisRead More »August 5, 2024Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024 Read More »May 17, 2024Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and Safety in Preclinical Models of Th17 Mediated Skin Inflammation in Oral Plenary Session at SID Annual MeetingRead More » More Press Releases Events and PresentationsMay 17, 2024STAT3 Plenary Presentation at Society for Investigative Dermatology (SID) Annual MeetingView Presentation »December 7, 2023STAT6 Program Highlighted in Sanofi R&D DayAccess Webcast »October 31, 20237th Annual Dermatology Drug Development SummitView Presentation »October 17, 2023International Conference of the Inflammation Research Association (IRA)View Presentation » More Events and Presentations News Coverage HighlightsAugust 7, 2023BioCentury: Recludix: targeting STATs via their SH2 domainsRead More »July 20, 2023BioWorld: Recludix enters a potential $1.2B deal with SanofiRead More »July 20, 2023SCRIP: Sanofi Adds To Immunology Pipeline In Collaboration With Recludix Read More »July 20, 2023Fierce Biotech: Sanofi pays $125M to go after undruggable inflammatory target with Recludix’s preclinical programRead More »July 20, 2023Endpoints News: Following Dupixent’s rise, Sanofi heads downstream in immunology for $125M small molecule pact with RecludixRead More »
